Nami McCarty
0000-0002-7384-5165
Publication & Citation Trends
Publications
0 total
The Identification of a Novel Biomarker Based on Lymphocyte Count, Albumin Level, and TBAg/PHA Ratio for Differentiation Between Active and Latent Tuberculosis Infection OA
Cited by 0
Semantic Scholar
Lower levels of BACH2 -mRNA and -protein are expressed in bortezomib resistant MCL cell lines and patient cells compared to bortezomib sensitive MCL cell lines and patient cells. OA
Cited by 0
Semantic Scholar
Abstract 3364: Calcium blockers decrease the bortezomib resistance in mantle cell lymphoma (MCL) via manipulation of tissue transglutaminase activities.
Cited by 2
Semantic Scholar
Research Topics
Autophagy in Disease and Therapy
(18)
Lymphoma Diagnosis and Treatment
(15)
Ubiquitin and proteasome pathways
(11)
Immune Cell Function and Interaction
(8)
Cancer-related molecular mechanisms research
(6)
Affiliations
Cleveland Clinic Lerner College of Medicine
Dana-Farber Cancer Institute
Brown Foundation
Texas A&M University
The University of Texas Health Science Center at Houston